Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locoregional Recurrence × exemestane × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 186 Neoplasm Metastasis 19 Neoplasms 6 Breast Neoplasms, Male 6 Ovarian Neoplasms 4 Breast Diseases 4 Obesity 3 Carcinoma, Intraductal, Noninfiltrating 3 Breast Carcinoma In Situ 3 Breast Cancer Metastatic 3 Recurrence 2 Prostatic Neoplasms 2 Multiple Endocrine Neoplasia Type 1 2 Endometrial Neoplasms 2 Carcinoma, Renal Cell 2 Carcinoma, Non-Small-Cell Lung 2 Bulbo-Spinal Atrophy, X-Linked 2 Arthralgia 2 Advanced Breast Cancer 2 Vitamin D Deficiency 1 Uterine Cervical Neoplasms 1 Tuberous Sclerosis 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sleep Wake Disorders 1 Skin Diseases 1 Sexuality 1 Primary Breast Cancer ER+ve 1 Premenopausal Breast Cancer 1 Post Menopausal Women With Early Breast Cancer 1

Interventions

ribociclib 1 exemestane 1 Letrozole 1 Fulvestrant 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05467891 2026-02-27

RaPhLRR

Hoosier Cancer Research Network

Phase 2 Recruiting

Locoregional Recurrence

Data powered by HemOnc (CC BY 4.0) Colophon ⚡